Glucose tolerance, insulin sensitivity and beta-cell function in patients with rheumatoid arthritis treated with or without low-to-medium dose glucocorticoids

GC-using and GC-naive patients with RA had comparable metabolic parameters, and had decreased insulin sensitivity and beta-cell function as compared with healthy controls. Although cumulative GC dose was shown to have a negative impact on glucose tolerance state and insulin sensitivity, confounding by indication remains the main challenge in this cross-sectional analysis.

 

 

Authors: Hoes, J. N.; van der Goes, M. C.; van Raalte, D. H.; van der Zijl, N. J.; den Uyl, D.; Lems, W. F.; Lafeber, F. P.; Jacobs, J. W.; Welsing, P. M.; Diamant, M.; Bijlsma, J. W. 

Title: Glucose tolerance, insulin sensitivity and beta-cell function in patients with rheumatoid arthritis treated with or without low-to-medium dose glucocorticoids

Year: 2011

Journal: Ann Rheum Dis

Volume: 70

Issue: 11

Pages: 1887-94

Pubmed Link: Click here.

 

Previous Article

Current view of glucocorticoid co-therapy with DMARDs in rheumatoid arthritis...

Next Article

Lessons for the use of non-biologic anchor treatments for rheumatoid...